- Title
- Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia : Rationale and design of the beyond Endorsed Lipid Lowering with EBT scanning (BELLES) trial
- Creators
- Paolo Raggi - Tulane University Health Sciences Center, New Orleans, La, United StatesTracy Q Callister - Electron Beam Tomography Research Foundation, Hendersonville, Tenn, United StatesMichael Davidson - Chicago Center for Clinical Research, Chicago, Ill, United StatesFrancine K Welty - Harvard Medical School, Boston, Mass, United StatesGloria A Bachmann - University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, United StatesRachel Laskey - Pfizer Inc, New York, NY, United StatesDonald Pittman - Pfizer Inc, New York, NY, United StatesStephanie Kafonek - Pfizer Inc, New York, NY, United StatesRobert Scott - Pfizer Inc, New York, NY, United States
- Publication Details
- The American heart journal, Vol.141(5), pp.722-726
- Date published
- 2001
- Publisher
- Elsevier
- Academic Unit
- Obstetrics, Gynecology, and Reproductive Sciences - General Obstetrics and Gynecology (RWJMS)
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031666009104646
Journal article
Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia : Rationale and design of the beyond Endorsed Lipid Lowering with EBT scanning (BELLES) trial
The American heart journal, Vol.141(5), pp.722-726
2001
PMID: 11320358
Metrics
16 Record Views